APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Anorexia-Cachexia Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cancer Anorexia-Cachexia Syndrome Drug Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchCancer Anorexia-Cachexia Syndrome Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Anorexia-Cachexia Syndrome Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cancer Anorexia-Cachexia Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Anorexia-Cachexia Syndrome Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Anorexia-Cachexia Syndrome Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cancer Anorexia-Cachexia Syndrome Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cancer Anorexia-Cachexia Syndrome Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cancer Anorexia-Cachexia Syndrome Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cancer Anorexia-Cachexia Syndrome Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cancer Anorexia-Cachexia Syndrome Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Cancer Anorexia-Cachexia Syndrome Drug include Novartis AG, Viking Therapeutics Inc, RaQualia Pharma Inc, PsiOxus Therapeutics Ltd, Obexia AG, Lakewood-Amedex Inc, Incyte Corp, Aphios Corp and Aeterna Zentaris Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cancer Anorexia-Cachexia Syndrome Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cancer Anorexia-Cachexia Syndrome Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Cancer Anorexia-Cachexia Syndrome Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cancer Anorexia-Cachexia Syndrome Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cancer Anorexia-Cachexia Syndrome Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cancer Anorexia-Cachexia Syndrome Drug sales, projected growth trends, production technology, application and end-user industry.

Cancer Anorexia-Cachexia Syndrome Drug Segment by Company

Novartis AG

Viking Therapeutics Inc

RaQualia Pharma Inc

PsiOxus Therapeutics Ltd

Obexia AG

Lakewood-Amedex Inc

Incyte Corp

Aphios Corp

Aeterna Zentaris Inc

Acacia Pharma Ltd

Cancer Anorexia-Cachexia Syndrome Drug Segment by Type

NEO-1940

Foxo1-nRNA

DLN-101

C-1889

AVGN-7

Others

Cancer Anorexia-Cachexia Syndrome Drug Segment by Application

Hospital

Clinic

Others

Cancer Anorexia-Cachexia Syndrome Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Anorexia-Cachexia Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Anorexia-Cachexia Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Anorexia-Cachexia Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Cancer Anorexia-Cachexia Syndrome Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Cancer Anorexia-Cachexia Syndrome Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Anorexia-Cachexia Syndrome Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. NEO-1940 Major Manufacturers Table 3. Foxo1-nRNA Major Manufacturers Table 4. DLN-101 Major Manufacturers Table 5. C-1889 Major Manufacturers Table 6. AVGN-7 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Hospital Major Manufacturers Table 10. Clinic Major Manufacturers Table 11. Others Major Manufacturers Table 12. Cancer Anorexia-Cachexia Syndrome Drug Industry Trends Table 13. Cancer Anorexia-Cachexia Syndrome Drug Industry Drivers Table 14. Cancer Anorexia-Cachexia Syndrome Drug Industry Opportunities and Challenges Table 15. Cancer Anorexia-Cachexia Syndrome Drug Industry Restraints Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2021-2026) Table 20. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2027-2032) Table 21. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2021-2026) & (K Units) Table 23. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2027-2032) & (K Units) Table 24. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2021-2026) Table 25. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2027-2032) Table 26. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2021-2026) Table 30. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Cancer Anorexia-Cachexia Syndrome Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Cancer Anorexia-Cachexia Syndrome Drug Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers, Product Type & Application Table 34. Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Cancer Anorexia-Cachexia Syndrome Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2021-2026) Table 41. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2027-2032) Table 42. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 44. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (K Units) Table 45. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2021-2026) Table 46. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2027-2032) Table 47. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2026) & (US$/Unit) Table 48. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2027-2032) & (US$/Unit) Table 49. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2021-2026) Table 53. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2027-2032) Table 54. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 56. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2021-2026) Table 58. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2027-2032) Table 59. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2026) & (US$/Unit) Table 60. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2027-2032) & (US$/Unit) Table 61. Novartis AG Company Information Table 62. Novartis AG Business Overview Table 63. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 65. Novartis AG Recent Development Table 66. Viking Therapeutics Inc Company Information Table 67. Viking Therapeutics Inc Business Overview Table 68. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 70. Viking Therapeutics Inc Recent Development Table 71. RaQualia Pharma Inc Company Information Table 72. RaQualia Pharma Inc Business Overview Table 73. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 75. RaQualia Pharma Inc Recent Development Table 76. PsiOxus Therapeutics Ltd Company Information Table 77. PsiOxus Therapeutics Ltd Business Overview Table 78. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 80. PsiOxus Therapeutics Ltd Recent Development Table 81. Obexia AG Company Information Table 82. Obexia AG Business Overview Table 83. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 85. Obexia AG Recent Development Table 86. Lakewood-Amedex Inc Company Information Table 87. Lakewood-Amedex Inc Business Overview Table 88. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 90. Lakewood-Amedex Inc Recent Development Table 91. Incyte Corp Company Information Table 92. Incyte Corp Business Overview Table 93. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 95. Incyte Corp Recent Development Table 96. Aphios Corp Company Information Table 97. Aphios Corp Business Overview Table 98. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 100. Aphios Corp Recent Development Table 101. Aeterna Zentaris Inc Company Information Table 102. Aeterna Zentaris Inc Business Overview Table 103. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 105. Aeterna Zentaris Inc Recent Development Table 106. Acacia Pharma Ltd Company Information Table 107. Acacia Pharma Ltd Business Overview Table 108. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 110. Acacia Pharma Ltd Recent Development Table 111. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 114. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (K Units) Table 115. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 116. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 117. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 118. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 119. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 120. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (K Units) Table 121. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 122. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 123. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 127. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 128. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 129. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 130. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 131. United States Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 132. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 133. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 136. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (K Units) Table 137. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 142. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (K Units) Table 143. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 150. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 151. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 154. France Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 155. U.K. Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 156. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 158. China Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 159. China Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 160. China Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 161. China Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (K Units) Table 162. China Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 163. China Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 164. China Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 165. China Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 166. China Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 167. China Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (K Units) Table 168. China Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 169. China Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 171. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 172. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 173. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (K Units) Table 174. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 175. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 176. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 177. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 178. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 179. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (K Units) Table 180. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 181. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 186. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 187. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 188. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 189. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 191. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 192. India Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 193. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 194. China Taiwan Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 195. Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 196. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 197. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 198. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 199. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (K Units) Table 200. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 201. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 202. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 203. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 204. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 205. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (K Units) Table 206. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 207. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 208. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 212. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 213. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 214. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 215. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 216. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 217. Argentina Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 218. Chile Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 219. Colombia Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 220. Peru Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 221. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 222. Israel Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 223. UAE Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 224. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 225. Iran Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 226. Egypt Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Table 227. Key Raw Materials Table 228. Raw Materials Key Suppliers Table 229. Cancer Anorexia-Cachexia Syndrome Drug Distributors List Table 230. Cancer Anorexia-Cachexia Syndrome Drug Customers List Table 231. Research Programs/Design for This Report Table 232. Authors List of This Report Table 233. Secondary Sources Table 234. Primary Sources List of Figures Figure 1. Cancer Anorexia-Cachexia Syndrome Drug Image Figure 2. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. NEO-1940 Image Figure 5. Foxo1-nRNA Image Figure 6. DLN-101 Image Figure 7. C-1889 Image Figure 8. AVGN-7 Image Figure 9. Others Image Figure 10. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Share 2021 VS 2025 VS 2032 Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2032) & (US$ Million) Figure 17. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2021-2032) Figure 20. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (2021-2032) & (K Units) Figure 21. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Cancer Anorexia-Cachexia Syndrome Drug Sales YoY (2021-2032) & (K Units) Figure 24. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales YoY (2021-2032) & (K Units) Figure 25. China Cancer Anorexia-Cachexia Syndrome Drug Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Cancer Anorexia-Cachexia Syndrome Drug Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales YoY (2021-2032) & (K Units) Figure 28. Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2021-2032) Figure 34. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2021-2032) Figure 37. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2021-2032) Figure 40. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2021-2032) Figure 43. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2021-2032) Figure 44. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2021-2032) Figure 45. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Application (2021-2032) Figure 46. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2021-2032) Figure 47. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Country (2021-2032) Figure 48. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country (2021-2032) Figure 49. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2021-2032) Figure 50. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2021-2032) Figure 51. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Application (2021-2032) Figure 52. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2021-2032) Figure 53. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Country (2021-2032) Figure 54. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country (2021-2032) Figure 55. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2021-2032) Figure 56. China Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2021-2032) Figure 57. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Application (2021-2032) Figure 58. China Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2021-2032) Figure 59. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2021-2032) Figure 60. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2021-2032) Figure 61. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Application (2021-2032) Figure 62. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2021-2032) Figure 63. Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Country (2021-2032) Figure 64. Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country (2021-2032) Figure 65. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Type (2021-2032) Figure 66. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Type (2021-2032) Figure 67. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Application (2021-2032) Figure 68. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Application (2021-2032) Figure 69. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Country (2021-2032) Figure 70. SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country (2021-2032) Figure 71. Cancer Anorexia-Cachexia Syndrome Drug Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Cancer Anorexia-Cachexia Syndrome Drug Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • NEO-1940
  • Foxo1-nRNA
  • DLN-101
  • C-1889
  • AVGN-7
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Viking Therapeutics Inc
  • RaQualia Pharma Inc
  • PsiOxus Therapeutics Ltd
  • Obexia AG
  • Lakewood-Amedex Inc
  • Incyte Corp
  • Aphios Corp
  • Aeterna Zentaris Inc
  • Acacia Pharma Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cancer Anorexia-Cachexia Syndrome Drug Market by Type
  3. 1.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 NEO-1940
  5. 1.2.3 Foxo1-nRNA
  6. 1.2.4 DLN-101
  7. 1.2.5 C-1889
  8. 1.2.6 AVGN-7
  9. 1.2.7 Others
  10. 1.3 Cancer Anorexia-Cachexia Syndrome Drug Market by Application
  11. 1.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Clinic
  14. 1.3.4 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Cancer Anorexia-Cachexia Syndrome Drug Market Dynamics
  1. 2.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Trends
  2. 2.2 Cancer Anorexia-Cachexia Syndrome Drug Industry Drivers
  3. 2.3 Cancer Anorexia-Cachexia Syndrome Drug Industry Opportunities and Challenges
  4. 2.4 Cancer Anorexia-Cachexia Syndrome Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region
  3. 3.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region
  9. 3.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturers
  2. 4.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers
  6. 4.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Cancer Anorexia-Cachexia Syndrome Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Cancer Anorexia-Cachexia Syndrome Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers, Product Type & Application
  13. 4.7 Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market CR5 and HHI
  16. 4.8.2 2025 Cancer Anorexia-Cachexia Syndrome Drug Tier 1, Tier 2, and Tier 3
5 Cancer Anorexia-Cachexia Syndrome Drug Market by Type
  1. 5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type
  2. 5.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type
  6. 5.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type
6 Cancer Anorexia-Cachexia Syndrome Drug Market by Application
  1. 6.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application
  2. 6.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application
  6. 6.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Viking Therapeutics Inc
  8. 7.2.1 Viking Therapeutics Inc Company Information
  9. 7.2.2 Viking Therapeutics Inc Business Overview
  10. 7.2.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  12. 7.2.5 Viking Therapeutics Inc Recent Developments
  13. 7.3 RaQualia Pharma Inc
  14. 7.3.1 RaQualia Pharma Inc Company Information
  15. 7.3.2 RaQualia Pharma Inc Business Overview
  16. 7.3.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  18. 7.3.5 RaQualia Pharma Inc Recent Developments
  19. 7.4 PsiOxus Therapeutics Ltd
  20. 7.4.1 PsiOxus Therapeutics Ltd Company Information
  21. 7.4.2 PsiOxus Therapeutics Ltd Business Overview
  22. 7.4.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  24. 7.4.5 PsiOxus Therapeutics Ltd Recent Developments
  25. 7.5 Obexia AG
  26. 7.5.1 Obexia AG Company Information
  27. 7.5.2 Obexia AG Business Overview
  28. 7.5.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  30. 7.5.5 Obexia AG Recent Developments
  31. 7.6 Lakewood-Amedex Inc
  32. 7.6.1 Lakewood-Amedex Inc Company Information
  33. 7.6.2 Lakewood-Amedex Inc Business Overview
  34. 7.6.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  36. 7.6.5 Lakewood-Amedex Inc Recent Developments
  37. 7.7 Incyte Corp
  38. 7.7.1 Incyte Corp Company Information
  39. 7.7.2 Incyte Corp Business Overview
  40. 7.7.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  42. 7.7.5 Incyte Corp Recent Developments
  43. 7.8 Aphios Corp
  44. 7.8.1 Aphios Corp Company Information
  45. 7.8.2 Aphios Corp Business Overview
  46. 7.8.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  48. 7.8.5 Aphios Corp Recent Developments
  49. 7.9 Aeterna Zentaris Inc
  50. 7.9.1 Aeterna Zentaris Inc Company Information
  51. 7.9.2 Aeterna Zentaris Inc Business Overview
  52. 7.9.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  54. 7.9.5 Aeterna Zentaris Inc Recent Developments
  55. 7.10 Acacia Pharma Ltd
  56. 7.10.1 Acacia Pharma Ltd Company Information
  57. 7.10.2 Acacia Pharma Ltd Business Overview
  58. 7.10.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  60. 7.10.5 Acacia Pharma Ltd Recent Developments
8 North America
  1. 8.1 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type
  2. 8.1.1 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2032)
  5. 8.2 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application
  6. 8.2.1 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2032)
  9. 8.3 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  10. 8.3.1 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Cancer Anorexia-Cachexia Syndrome Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type
  2. 9.1.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2032)
  5. 9.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application
  6. 9.2.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2032)
  9. 9.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  10. 9.3.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type
  2. 10.1.1 China Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032)
  4. 10.1.3 China Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2032)
  5. 10.2 China Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application
  6. 10.2.1 China Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032)
  8. 10.2.3 China Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type
  2. 11.1.1 Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2032)
  5. 11.2 Asia Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application
  6. 11.2.1 Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2032)
  9. 11.3 Asia Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  10. 11.3.1 Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Cancer Anorexia-Cachexia Syndrome Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type
  2. 12.1.1 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application
  6. 12.2.1 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  10. 12.3.1 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Cancer Anorexia-Cachexia Syndrome Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Cancer Anorexia-Cachexia Syndrome Drug Value Chain Analysis
  2. 13.1.1 Cancer Anorexia-Cachexia Syndrome Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Cancer Anorexia-Cachexia Syndrome Drug Production Mode & Process
  6. 13.2 Cancer Anorexia-Cachexia Syndrome Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors
  9. 13.2.3 Cancer Anorexia-Cachexia Syndrome Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst